MODERATOR(S)
LeMoyne Habimana-Griffin, MD, PhD - University of Wisconsin
session DESCRIPTION
Emerging research shows that the microbiome plays a critical role in shaping tumor responses and anti-tumor immunity during radiation therapy. This session will highlight novel mechanisms by which the microbiome interacts with radiation to influence both tumor biology and immune responses, moving beyond classical microbiome-radiation discussions that focus primarily on toxicity or high-dose effects. Talks will cover low-dose radiation and immune modulation, tumor-intrinsic microbiome effects, and microbiome-immune crosstalk shaping tumor responses. Attendees will gain insight into forward-looking concepts and translational opportunities at the intersection of radiation therapy, the microbiome and immunity.
learning objectives
- Describe the role of low-dose radiation in modulating immune responses in the context of microbiome interactions.
- Summarize tumor-intrinsic and immune-mediated mechanisms by which the microbiome regulates radiation sensitivity.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
12:30pm - 12:32pm ETSpeaker: LeMoyne Habimana-Griffin, MD, PhD - University of Wisconsin, Madison
-
12:32pm - 12:52pm ETSpeaker: Eric Deutsch, MD, PhD - Gustave Roussy Cancer Campus, Villejuif
-
12:52pm - 01:12pm ETSpeaker: Stephen Shiao, MD, PhD - Cedars-Sinai Medical Center, Los Angeles
-
01:12pm - 01:32pm ETSpeaker: Andrea Facciabene, PhD - University of Pennsylvania Radiation Oncology, Philadelphia
-
01:32pm - 01:45pm ETSpeaker: LeMoyne Habimana-Griffin, MD, PhD - University of Wisconsin, Madison